Fennec Pharmaceuticals Inc. (FENC) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
Earnings Reports
-
Fennec (FENC) Q1 2026: PEDMARK Sales Surge 73% as Commercial Expansion Unlocks New Patient Access
May 14, 2026
-
FENIC Pharmaceuticals (FENC) Q4 2025: PEDMARK Conversion Rate Jumps to 70% as AYA Expansion Accelerates
March 24, 2026
-
Fennec Pharmaceuticals (FENC) Q2 2025: PEDMARK Drives 33% Growth as AYA Adoption Accelerates
August 14, 2025